Early mortality in patients with cancer treated with immune checkpoint inhibitors in routine practice.

Jacques Raphael,Lucie Richard,Melody Lam,Phillip Blanchette,Natasha B Leighl,George Rodrigues,Maureen Trudeau,Monika K Krzyzanowska

Journal of the National Cancer Institute（2023）

引用 0|浏览6

暂无评分

摘要

EM is common among patients treated with ICI in the real-world setting and is associated with several patient and tumor characteristics. Development of a validated tool to predict EM may facilitate better patient selection for treatment with ICI in routine practice.

查看译文

关键词

immune checkpoint inhibitors,early mortality,cancer

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要